Masimo Corp Files Definitive Additional Materials

Ticker: MASI · Form: DEFA14A · Filed: Sep 17, 2024 · CIK: 937556

Masimo CORP DEFA14A Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form TypeDEFA14A
Filed DateSep 17, 2024
Risk Levellow
Pages14
Reading Time17 min
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, sec-filing, corporate-governance

Related Tickers: MASI

TL;DR

Masimo filed more proxy docs, no fee. Shareholders get updated info.

AI Summary

Masimo Corporation filed definitive additional materials on September 17, 2024, related to its proxy statement. The filing indicates no fee was required for this submission, which is an amendment or supplement to previously filed proxy materials under Schedule 14A.

Why It Matters

This filing provides updated or supplementary information to shareholders regarding matters to be voted on at a company meeting, impacting shareholder decisions and corporate governance.

Risk Assessment

Risk Level: low — This filing is administrative in nature, providing additional materials for a proxy statement, and does not introduce new financial or operational risks.

Key Players & Entities

FAQ

What type of SEC filing is this?

This is a DEFA14A filing, specifically 'Definitive Additional Materials' filed by Masimo Corporation.

Who is the filing company?

The filing company is Masimo Corporation.

What is the filing date?

The filing date is September 17, 2024.

Was a fee required for this filing?

No fee was required for this filing, as indicated by the 'No fee required' checkbox being selected.

What is the purpose of a DEFA14A filing?

A DEFA14A filing is used to provide definitive additional materials to supplement or amend a previously filed proxy statement (Schedule 14A) to shareholders.

Filing Stats: 4,136 words · 17 min read · ~14 pages · Grade level 15.6 · Accepted 2024-09-16 21:28:34

Filing Documents

From the Filing

ADDITIONAL MATERIALS UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 MASIMO CORPORATION (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. On September 16, 2024, Masimo Corporation (“Masimo” or the “Company”) made updates to its website, www.ProtectMasimosFuture.com, in connection with the 2024 Annual Meeting of Stockholders. A copy of the updated website content (other than content previously filed) can be found below. Homepage Update 1 2 3 4 5 6 Press Releases & Filings Section Update 7 8 Press Releases – Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers Comprehensive Platform Combines Masimo’s Industry-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Expand the Wear OS by Google™ Ecosystem Masimo (NASDAQ: MASI) a leading global medical innovator, and Qualcomm Technologies, Inc. , whose Snapdragon ® branded platforms power extraordinary consumer experiences, today announced that Masimo is partnering with Qualcomm Technologies to develop a next-generation smartwatch reference platform for original equipment manufacturers (OEMs) building Wear OS by Google smartwatches. The powerhouse combination of Masimo’s clinically proven, breakthrough biosensing technologies – based on its decades of expertise designing industry-leading hospital monitoring solutions – and best-in-class Snapdragon wearable platforms will help scale the wearable ecosystem. Forging the future of wearable devices, the reference platform will allow OEMs to more efficiently build and bring high-performing, premium smartwatches to market. The platform will also benefit from a robust suite of Masimo health and wellness tracking tools that consumers can trust to provide accurate, reliable data; it will use exclusively high-performance and ultra-low power system-on-a-chips (SoCs) alongside industry-leading wireless and cellular communications from Qualcomm Technologies to enable a superior connectivity experience. 9 Joe Kiani, Founder and CEO of Masimo, said, “We’re thrilled to be able to partner with Qualcomm Technologies, to whom we naturally turned to supply the chips in our own forthcoming Masimo Freedom™ wearable, to craft a truly remarkable reference platform. It’s a platform driven by the belief that when key smartwatch components are supplied by the leading experts in their field, the harmonious whole produces something even greater than the sum of those excellent parts. In short, Qualcomm Technologies and Masimo engineers are working together to optimize the ‘guts’ of the smartwatch. Masimo’s ability to craft precision monitoring technologies and advanced signal processing algorithms, combined with meticulously engineered, high-performing, low-power Snapdragon systems, is a compelling foundation. We expect this new wearable platform to supercharge smartwatch OEMs’ abilities to create competitive, desirable smartwatches for consumers everywhere. I look forward to partnering with a company as well known for its commitment to innovation as Masimo.” Dino Bekis, Vice President and General Manager, Wearables and Mixed Signal Solutions at Qualcomm Technologies, Inc., said, “Beginning with Snapdragon W5+ Gen 1, this collaboration will significantly broaden the range of smartwatch choices for consumers and further enhance the already exceptional Wear OS experience. With these reference designs, OEMs will benefit from robust, production-ready designs, incorporating Masimo’s state-of-the-art biosensing technology and Qualcomm Technologies’ leading Snapdragon wearable platforms. It will ultimately enable them to seamlessly bring their smartwatches to market rapidly and at scale.” OEMs who adopt the new reference platform will continue to design and produce their new smartw

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing